← Browse by Condition
Medical Condition

endometrial carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT07216105 Phase 1
Recruiting

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Enrollment
113 pts
Location
United States
Sponsor
Fate Therapeutics
View Trial →